These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19351857)

  • 1. Immune rejection of mouse tumors expressing mutated self.
    Duan F; Lin Y; Liu C; Engelhorn ME; Cohen AD; Curran M; Sakaguchi S; Merghoub T; Terzulli S; Wolchok JD; Houghton AN
    Cancer Res; 2009 Apr; 69(8):3545-53. PubMed ID: 19351857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved tumor immunity using anti-tyrosinase related protein-1 monoclonal antibody combined with DNA vaccines in murine melanoma.
    Saenger YM; Li Y; Chiou KC; Chan B; Rizzuto G; Terzulli SL; Merghoub T; Houghton AN; Wolchok JD
    Cancer Res; 2008 Dec; 68(23):9884-91. PubMed ID: 19047169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentivector immunization stimulates potent CD8 T cell responses against melanoma self-antigen tyrosinase-related protein 1 and generates antitumor immunity in mice.
    Liu Y; Peng Y; Mi M; Guevara-Patino J; Munn DH; Fu N; He Y
    J Immunol; 2009 May; 182(10):5960-9. PubMed ID: 19414747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of the glucocorticoid-induced TNF receptor family-related receptor on CD8 T cells induces protective and high-avidity T cell responses to tumor-specific antigens.
    Côté AL; Zhang P; O'Sullivan JA; Jacobs VL; Clemis CR; Sakaguchi S; Guevara-Patiño JA; Turk MJ
    J Immunol; 2011 Jan; 186(1):275-83. PubMed ID: 21106849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single heteroclitic epitope determines cancer immunity after xenogeneic DNA immunization against a tumor differentiation antigen.
    Gold JS; Ferrone CR; Guevara-Patiño JA; Hawkins WG; Dyall R; Engelhorn ME; Wolchok JD; Lewis JJ; Houghton AN
    J Immunol; 2003 May; 170(10):5188-94. PubMed ID: 12734366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid-induced TNF receptor family related gene activation overcomes tolerance/ignorance to melanoma differentiation antigens and enhances antitumor immunity.
    Ramirez-Montagut T; Chow A; Hirschhorn-Cymerman D; Terwey TH; Kochman AA; Lu S; Miles RC; Sakaguchi S; Houghton AN; van den Brink MR
    J Immunol; 2006 Jun; 176(11):6434-42. PubMed ID: 16709800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of a self antigen for presentation of multiple epitopes in cancer immunity.
    Guevara-Patiño JA; Engelhorn ME; Turk MJ; Liu C; Duan F; Rizzuto G; Cohen AD; Merghoub T; Wolchok JD; Houghton AN
    J Clin Invest; 2006 May; 116(5):1382-90. PubMed ID: 16614758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful adoptive immunotherapy of murine poorly immunogenic tumor with specific effector cells generated from gene-modified tumor-primed lymph node cells.
    Tanaka H; Yoshizawa H; Yamaguchi Y; Ito K; Kagamu H; Suzuki E; Gejyo F; Hamada H; Arakawa M
    J Immunol; 1999 Mar; 162(6):3574-82. PubMed ID: 10092816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTL activation using the natural low-affinity epitope 222-229 from tyrosinase-related protein 1 leads to tumor rejection.
    Pavelko KD; Hansen MJ; Pease LR
    Cancer Res; 2009 Apr; 69(7):3114-20. PubMed ID: 19276379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Provision of granulocyte-macrophage colony-stimulating factor converts an autoimmune response to a self-antigen into an antitumor response.
    Ji Q; Gondek D; Hurwitz AA
    J Immunol; 2005 Aug; 175(3):1456-63. PubMed ID: 16034082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control.
    Vianello F; Papeta N; Chen T; Kraft P; White N; Hart WK; Kircher MF; Swart E; Rhee S; Palù G; Irimia D; Toner M; Weissleder R; Poznansky MC
    J Immunol; 2006 Mar; 176(5):2902-14. PubMed ID: 16493048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma.
    Goldszmid RS; Idoyaga J; Bravo AI; Steinman R; Mordoh J; Wainstok R
    J Immunol; 2003 Dec; 171(11):5940-7. PubMed ID: 14634105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells.
    Turk MJ; Guevara-Patiño JA; Rizzuto GA; Engelhorn ME; Sakaguchi S; Houghton AN
    J Exp Med; 2004 Sep; 200(6):771-82. PubMed ID: 15381730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An exhaustion-like phenotype constrains the activity of CD4+ T cells specific for a self and melanoma antigen.
    Rausch MP; Hastings KT
    PLoS One; 2015; 10(4):e0123332. PubMed ID: 25875653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunity.
    Cohen AD; Diab A; Perales MA; Wolchok JD; Rizzuto G; Merghoub T; Huggins D; Liu C; Turk MJ; Restifo NP; Sakaguchi S; Houghton AN
    Cancer Res; 2006 May; 66(9):4904-12. PubMed ID: 16651447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implicating a role for immune recognition of self in tumor rejection: passive immunization against the brown locus protein.
    Hara I; Takechi Y; Houghton AN
    J Exp Med; 1995 Nov; 182(5):1609-14. PubMed ID: 7595233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aire deficiency promotes TRP-1-specific immune rejection of melanoma.
    Zhu ML; Nagavalli A; Su MA
    Cancer Res; 2013 Apr; 73(7):2104-16. PubMed ID: 23370329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of immunogenic and effective multi-epitope DNA vaccines for melanoma.
    Cho HI; Celis E
    Cancer Immunol Immunother; 2012 Mar; 61(3):343-51. PubMed ID: 21915800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of tumor-specific immunity in mice by immunization with reconstituted tumor membrane liposomes containing recombinant B7-2 (CD86).
    Westerman LE; Sund SC; Selvaraj P; Jensen PE
    J Immunother; 2000; 23(4):456-63. PubMed ID: 10916755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A thyroid tumor-specific antigen formed by the fusion of two self proteins.
    Powell DJ; Eisenlohr LC; Rothstein JL
    J Immunol; 2003 Jan; 170(2):861-9. PubMed ID: 12517951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.